APA (7th ed.) Citation

DJ, v. D., KMA, v. E., K, d. W., LC, B., M, K., BJ, V., . . . RB, T. (2025). Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization. United European gastroenterology journal, 13(6), 938. https://doi.org/10.1002/ueg2.12767

Chicago Style (17th ed.) Citation

DJ, van Doorn, et al. "Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization." United European Gastroenterology Journal 13, no. 6 (2025): 938. https://doi.org/10.1002/ueg2.12767.

MLA (9th ed.) Citation

DJ, van Doorn, et al. "Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization." United European Gastroenterology Journal, vol. 13, no. 6, 2025, p. 938, https://doi.org/10.1002/ueg2.12767.